Skip to Main Content
Table I.

Age and sex of CMV-seropositive subjects and total frequency of response to peptide epitopes

Subject
Age (Sex)
Peptide (Class II restriction)
Location
Total response
64 (M) QEFFWDANDIYRIFA (DR52) pp65281–295 0.88% 
55 (F) LLQTGIHVRVSQPSL (DR15) pp6541–55 0.64% 
58 (F) LLQTGIHVRVSQPSL (DR15) pp6541–55 0.28% 
44 (M) PPWQAGILARNLVPMV (DR11) pp65485–500 0.2% 
  IIKPGKISHIMLDVA (DR53) pp65281–295 0.2% 
23 (M) PQYSEHPTFTSQYRIQ (DR11) pp65361–376 0.2% 
37 (M) PQYSEHPTFTSQYRIQ (DR11) pp65361–376 0.2% 
61 (M) QEFFWDANDIYRIFA (DR52) pp65281–295 0.39% 
Subject
Age (Sex)
Peptide (Class II restriction)
Location
Total response
64 (M) QEFFWDANDIYRIFA (DR52) pp65281–295 0.88% 
55 (F) LLQTGIHVRVSQPSL (DR15) pp6541–55 0.64% 
58 (F) LLQTGIHVRVSQPSL (DR15) pp6541–55 0.28% 
44 (M) PPWQAGILARNLVPMV (DR11) pp65485–500 0.2% 
  IIKPGKISHIMLDVA (DR53) pp65281–295 0.2% 
23 (M) PQYSEHPTFTSQYRIQ (DR11) pp65361–376 0.2% 
37 (M) PQYSEHPTFTSQYRIQ (DR11) pp65361–376 0.2% 
61 (M) QEFFWDANDIYRIFA (DR52) pp65281–295 0.39% 

Total response represents the sum of all CD4+ T cells showing surface mobilization of CD107, or production of IFN-γ, IL-2, MIP-1β, or TNF-α in response to stimulation with the peptide indicated.

Close Modal

or Create an Account

Close Modal
Close Modal